Reaction

Catheter Site Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,690 reports · 106 co-occurring drugs

As of the last recalculation, Catheter Site Infection appears in 3,690 FAERS reports alongside 106 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 155.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Epoprostenol	328	155.0	159.0
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	170	113.6	115.8
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	246	47.8	48.2
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	49	34.2	34.4
Macitentan	273	23.9	24.0
Teduglutide	53	22.5	22.6
Bosentan	161	18.8	18.9
Sildenafil Powder,	113	18.4	18.5
Sildenafil	177	18.1	18.1
Treprostinil	305	14.9	14.9
Tadalafil	247	14.8	14.9
Sildenafil Citrate	304	14.6	14.6
Riociguat	74	13.0	13.1
0Xygen	105	12.3	12.4
Oxygen	105	12.3	12.4
Selexipag	53	11.7	11.7
Micafungin Sodium	16	10.7	10.7
Ambrisentan	187	8.8	8.9
Paricalcitol	22	8.8	8.8
Azacitidine For	28	8.7	8.8
Daptomycin	14	8.6	8.6
Posaconazole Delayed-Release	16	8.2	8.3
Sevelamer Carbonate	16	7.9	7.9
Dronabinol	11	7.7	7.7
Azacitidine	38	7.3	7.3
Ado-Trastuzumab Emtansine	10	6.7	6.7
Gentamicin Sulfate	18	6.5	6.5
Basiliximab	13	6.3	6.3
Posaconazole	17	5.9	5.9
Eculizumab	56	5.9	5.9
Calcitriol Capsules 0.25 Mcg	20	5.7	5.7
Calcitriol Capsules 0.5 Mcg	20	5.7	5.7
Gentamicin	13	5.6	5.6
Sodium Bicarbonate	23	5.6	5.6
Sodium Bicarbonate Injection,	23	5.6	5.6
Calcitriol	20	5.6	5.6
Blinatumomab	10	5.4	5.4
Potassium Chloride, Dextrose Monohydrate	86	5.3	5.3
Potassium Chloride Oral	86	5.3	5.3
Potassium Chloride Extended-Release	86	5.3	5.3
Spironolactone	129	5.3	5.3
Cefazolin Sodium	11	5.2	5.2
Warfarin	111	5.1	5.1
Metolazone	10	5.0	5.0
Bisacodyl	12	4.8	4.8
Bisacodyl Suppositories	11	4.8	4.8
Biscodyl	11	4.8	4.8
Potassium Chloride	94	4.7	4.8
Sodium Chloride Tablet	61	4.7	4.7
Sodium Chloride Tablets	61	4.7	4.7
Cefepime	12	4.7	4.7
Busulfan	13	4.7	4.7
Tolvaptan	12	4.7	4.7
Cefepime Hydrochloride	13	4.6	4.6
Sodium Chloride	63	4.6	4.6
Heparin Sodium	11	4.5	4.5
Paclitaxel (Aibumin-Bound)	64	4.5	4.5
Amantadine	12	4.4	4.4
Vincristine Sulfate	22	4.3	4.3
Polyethylene Glycol	8	4.2	4.2
Vancomycin Hydrochloride	48	4.1	4.2
Paclitaxel	71	4.1	4.1
Mesna Injection	6	4.1	4.1
Buspirone Hydrochloride	8	4.1	4.1
Mesna	6	4.0	4.0
Doxorubicin Hydrochloride	23	4.0	4.0
Vancomycin	40	3.9	3.9
Bumetanide	18	3.9	3.9
Ferrous Sulfate	34	3.8	3.8
Fexofenadine Hcl	6	3.7	3.7
Panitumumab	10	3.6	3.6
Fluorouracil	49	3.6	3.6
Iron Sucrose	6	3.6	3.6
Loperamide Hydrochloride And Dimethicone	20	3.5	3.5
Irinotecan Hydrochloride	8	3.5	3.5
Fluorouracil Cream, 0.5%	47	3.5	3.5
Atovaquone	5	3.5	3.5
Cytarabine	35	3.3	3.3
Erythropoietin	12	3.3	3.3
Pegaspargase	7	3.2	3.2
Methoxy Polyethylene Glycol-Epoetin Beta	6	3.1	3.1
Rasagiline Mesylate	6	3.0	3.0
Acyclovir	59	2.9	2.9
Cisplatin	40	2.9	2.9
Ifosfamide	11	2.9	2.9
Guanfacine	4	2.9	2.9
Venetoclax	30	2.8	2.8
Brentuximab Vedotin	5	2.8	2.8
Oxaliplatin	35	2.7	2.7
Carboplatin	56	2.5	2.5
Agalsidase Beta	4	2.4	2.4
Doxorubicin	37	2.4	2.4
Cetuximab	13	2.3	2.3
Dapagliflozin	13	2.3	2.3
Fam-Trastuzumab Deruxtecan-Nxki	4	2.2	2.2
Nintedanib	12	2.2	2.2
Vibegron	3	2.1	2.1
Carfilzomib	10	2.0	2.0
Abiraterone	4	1.7	1.7
Palivizumab	4	1.5	1.5
Rimegepant Sulfate	3	1.3	1.3
Patiromer	3	1.2	1.2
Pomalidomide	20	1.1	1.1
Pegfilgrastim	17	1.0	1.0
Pirfenidone	7	1.0	1.0
Cinacalcet Hydrochloride	8	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.